ANI Pharmaceuticals bids $560M for Egetis Therapeutics
ANI Pharmaceuticals offers $560M to acquire Egetis Therapeutics, aiming to expand its rare disease portfolio with Emcitate therapy.
Picky Eating Common in Toddlers, Experts Offer Guidance
Picky eating affects 25%-66% of toddlers, and pediatric experts explain why it peaks between 18 months and two…
SEHA Al Dhafra Hosts Health Forum Featuring AI
From November 4 to 6, 2026, SEHA Al Dhafra Hospitals will convene its fifth annual Health Forum at…
ANI Pharmaceuticals bids $560M for Egetis Therapeutics
ANI Pharmaceuticals offers $560M to acquire Egetis Therapeutics, aiming to expand its rare disease portfolio with Emcitate therapy.
Diabetes damages kidneys via high blood sugar
Diabetes damages kidneys via high blood sugar, raising chronic kidney disease risk. Up to 40% of people with…
Boehringer Ingelheim partners with Sino Biopharmaceutical
Boehringer Ingelheim partners with Sino Biopharmaceutical in a $7.4 billion cancer drug development deal.